Retail Investors Buy The Omicron Market Dip

Retail Investors Buy The Omicron Market Dip
Andrew Rummer

over 2 years ago1 min

Mentioned in story

Retail investors’ purchases of US stocks hit a fresh record on Tuesday as they stepped in to buy the latest coronavirus-inspired market dip.

The S&P 500 fell nearly 3% in the three trading days following the Thanksgiving holiday on news that the latest coronavirus variant – dubbed Omicron – had a large number of mutations that could make existing vaccines less effective. But the chart above shows how the sea of red inspired little fear among smaller investors: they bought $2.1 billion of US stocks on Friday and another $2.2 billion on Tuesday.

Again and again since the pandemic first spooked markets in March 2020, retail investors have jumped in to buy stocks whenever they’ve fallen. And, mostly, that bravado has been heartily rewarded as markets rebounded to set fresh all-time highs. As the months have gone by, however, an intriguing trend has developed. The chart below suggests that smaller investors are trading less (the yellow line) but those remaining in the markets are buying rather than selling (the blue line).

Retail trading chart

If those bullish retail investors continue to step in at any hint of red in stocks, it should help limit any losses as we head towards the conclusion of 2021. 



All the daily investing news and insights you need in one subscription.

Disclaimer: These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment advisor.

/3 Your free quarterly content is about to expire. Uncover the biggest trends and opportunities. Subscribe now for 50%. Cancel anytime.

© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG